USA – Eli Lilly has formed a multi-year collaboration with China-based Regor Therapeutics Group to discover and develop new therapies for metabolic disorders in a deal that will see the…
Read MoreTag: autoimmune disease
Glaxo’s biological agent offers a glimmer of hope for lupus patients
CHINA – GlaxoSmithKline plc has unveiled the world’s first biological agent, Benlysta for the treatment of lupus nephritis at the 4th China International Import Expo. Lupus nephritis is a kidney…
Read More